Back to compounds

COMPOUND PROFILE / SMALL MOLECULES

Capromorelin.

Research draft

Capromorelin is a small-molecule ghrelin-receptor agonist.

Keep the context.

Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.

Targeted source and identity review, not a systematic review or complete regulatory audit.

Overview

Capromorelin is a small-molecule ghrelin-receptor agonist.

CLASSIFICATIONSmall molecules
MOLECULAR / SEQUENCE INFONot specified
PRIMARY CONTEXTCompound

Mechanism

It influences appetite and growth-hormone-related signalling.

Human research

Human pharmacology studies exist, but they do not establish an approved human enhancement use.

Preclinical & other research

Preclinical and veterinary work must remain separate from human outcomes.

Safety & unknowns

Endocrine and glucose effects require attention; animal dosing cannot determine human safety.

Regulatory status

Veterinary authorisation does not establish human medicine approval.

Reported use & evidence

Research profile draft

The supplied Capromorelin profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.

Sources & references

Explore more compounds